| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LivaNova PLC | Director | Restricted Stock Units | 3.42K | $187K | $54.81 | Jun 15, 2024 | Direct |
| LivaNova PLC | Director | Ordinary Shares | 3.48K | $183K | $52.68 | Jun 15, 2024 | Direct |
| Sigilon Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 8.89K | $6.67K | $0.75 | May 26, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LIVN | LivaNova PLC | Jun 15, 2024 | 4 | -$30.8K | 4 | Jun 18, 2024 | Director |
| LIVN | LivaNova PLC | Sep 15, 2023 | 3 | -$19.9K | 4 | Sep 19, 2023 | Director |
| LIVN | LivaNova PLC | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
| LIVN | LivaNova PLC | Sep 15, 2022 | 0 | $0 | 3 | Sep 19, 2022 | Director |
| LIVN | LivaNova PLC | Sep 15, 2022 | 1 | $0 | 4 | Sep 19, 2022 | Director |
| SGTX | Sigilon Therapeutics, Inc. | May 26, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
| SGTX | Sigilon Therapeutics, Inc. | Jun 14, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director |
| SGTX | Sigilon Therapeutics, Inc. | Jun 14, 2021 | 0 | $0 | 3 | Jun 16, 2021 | Director |